PATH
Seattle, Washington, United States
Purpose
to test whether inactivated polio vaccine delivered intramuscularly with double mutant heat-labile toxin of E. coli induces gut mucosal immune responses and decreases shedding of poliovirus, reducing transmission in the population
Division
Global Development, Global Health
Date
October 2017
Region Served
GLOBAL
Committed amount
$2,698,144
Grant topic
Discovery and Translational Sciences, Polio
Duration (months)
59
Grantee location
Seattle, Washington, United States
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.